A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

Keyphrases

• Clinical Trials 100%
• Angioplasty 100%
• Acute Myocardial Infarction 100%
• Tissue Plasminogen Activator (t-PA) 100%
• Primary Coronary Angioplasty 100%
• Thrombolytic Therapy 75%
• Heparin 50%
• Hirudin 50%
• Clinical Benefit 50%
• Reinfarction 50%
• Primary Angioplasty 50%
• Non-fatal 50%
• Composite Outcome 50%
• Coronary Artery 25%
• No Significant Difference 25%
• Acute Coronary Syndrome 25%
• Confidence Interval 25%
• Odds Ratio 25%
• Recombinant Tissue Plasminogen Activator (rt-PA) 25%
• Coronary Angioplasty 25%
• Myocardial Ischemia-reperfusion 25%
• GUSTO 25%
• Factorial Design 25%
• Global Use 25%
• Acute Myocardial Infarction with ST-segment Elevation 25%

Medicine and Dentistry

• Clinical Trial 100%
• Angioplasty 100%
• Acute Heart Infarction 100%
• Transluminal Coronary Angioplasty 100%
• Tissue Plasminogen Activator 100%
• Fibrinolytic Therapy 50%
• Heparin 33%
• Apoplexy 33%
• Hirudin 33%
• Acute Coronary Syndrome 16%
• Odds Ratio 16%
• Coronary Artery 16%
• Electrocardiogram 16%
• Alteplase 16%
• ST Elevation 16%
• Heart Muscle Reperfusion 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Acute Heart Infarction 100%
• Tissue Plasminogen Activator 100%
• Fibrinolytic Agent 75%
• Hirudin 50%
• Heparin 50%
• Cerebrovascular Accident 50%
• Acute Coronary Syndrome 25%
• Alteplase 25%